Latest Commercialization News

Temple & Webster delivered record FY26 revenue of $664.6 million and lifted underlying EBITDA by 28%, despite a sharp fall in statutory profit after tax. The online retailer is targeting EBITDA of $33 million to $40 million in FY27 as improved margins, exclusive products and adjacent categories do more of the heavy lifting.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Structural Monitoring Systems (ASX:SMN) delivered record FY26 revenue, a sharp lift in profit and $6.0 million of free cash flow as its avionics business outpaced contract manufacturing. The balance sheet is now free of bank debt, but the next leg of the story still depends on FAA approvals and converting CVM technology into commercial revenue.

Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.

Alliance Nickel has approved a second phase of vat leach testing after preliminary NiWest results supported continued evaluation of the alternative processing route. The potential prize is substantial, but quantified recoveries and capital savings remain unproven.

SRJ Technologies has secured a US$1.234 million purchase order for an LNG controls upgrade supporting a Middle Eastern National Oil Company. The award adds revenue across FY26 and FY27 while giving SRJ a less site-dependent route to build its Gulf credentials.

Tungsten Mining says non-binding debt proposals could fund up to 70% of its Watershed project, equivalent to about A$200 million against estimated pre-production capital of A$274 million. The financing remains uncommitted, with strategic investment, offtake and government-backed options still in play.

Deterra Royalties has paid US$74.15 million for a royalty covering most of Ivanhoe Electric’s Santa Cruz copper project in Arizona. The deal adds a third core asset, but its projected returns still depend on financing, permitting and a targeted 2029 production start.

Besra Gold’s FY2026 report puts its Gold Purchase Agreement with major shareholder Quantum Metal Recovery at the centre of the company’s financial risk profile. Funding received under the deal has been recorded as a contract liability tied to potential future gold deliveries, while the report also discloses an AU$140,000 payment to a former director.

Acrow Limited (ASX: ACF) is targeting a sharp FY27 earnings lift after industrial access revenue exceeded $200 million and post-year-end acquisitions expanded its platform. The FY26 result was more mixed: revenue reached a record $336 million, but underlying net profit fell 20% and the dividend was reduced.

Viridis Mining and Minerals Limited (ASX:VMM) has used its FY2026 annual report to present Colossus as a rare earths project moving from study work into execution. The company has reported strong DFS economics and fresh equity funding, but still needs key permits, binding offtake and senior debt before construction can fully proceed.

Spacetalk Limited (ASX:SPA) has posted a sharply deeper FY26 loss and negative net assets, while its auditor flagged a material uncertainty over the company’s ability to continue as a going concern. The company says a $10 million post-year-end placement, note conversions and new telco agreements give its software-led strategy room to execute.